MEDICAMEQ.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 05:59):

Stats
Today's Volume	368 888
Average Volume	43 152.00
Market Cap	7.38B
EPS	INR0 ( 2024-02-11 )
Next earnings date	( INR0 ) 2024-05-27
Last Dividend	INR1.000 ( 2022-09-19 )
Next Dividend	INR0 ( N/A )
P/E	64.49
ATR14	INR0 (0.00%)

Volume Correlation

Long: 0.00 (neutral)

Short: 0.00 (neutral)

Signal:(74.853) Neutral

Medicamen Biotech Limited Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Medicamen Biotech Limited Correlation - Currency/Commodity

0.00
( neutral )

0.54
( weak )

0.00
( neutral )

Medicamen Biotech Limited Financials

Annual	2022
Revenue:	INR1.41B
Gross Profit:	INR687.74M (48.82 %)
EPS:	INR11.92

FY	2022
Revenue:	INR1.41B
Gross Profit:	INR687.74M (48.82 %)
EPS:	INR11.92

FY	2022
Revenue:	INR1.15B
Gross Profit:	INR479.88M (41.57 %)
EPS:	INR12.19

FY	2021
Revenue:	INR1.13B
Gross Profit:	INR335.16M (29.74 %)
EPS:	INR9.93

Financial Reports:

No articles found.

Medicamen Biotech Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR1.000 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Medicamen Biotech Limited Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.57 - low (18.86%) | Divividend Growth Potential Score: 2.46 - Decrease likely (50.82%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.000	2022-09-19
Last Dividend	INR1.000	2022-09-19
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	INR1.000	--
Avg. Dividend % Per Year	0.02%	--
Score	1.43	--
Div. Sustainability Score	3.57
Div.Growth Potential Score	2.46
Div. Directional Score	3.02	--

Next Divdend (Est)
(2024-04-29)

INR0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

1.43

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2022	INR1.000	0.10%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SCI.NS	Dividend Junior	2023-09-01	Sporadic	22	0.25%
MALLCOM.NS	Dividend Junior	2023-09-04	Annually	3	0.20%
GOKEX.NS	Dividend Junior	2023-09-13	Sporadic	20	0.07%
AUTOAXLES.NS	Dividend Junior	2023-07-27	Annually	22	0.72%
TRENT.NS	Dividend Junior	2023-05-25	Annually	21	0.10%
PIDILITIND.NS	Dividend Junior	2023-07-27	Annually	23	0.29%
JINDRILL.NS	Dividend Junior	2023-08-14	Annually	18	0.23%
DELTACORP.NS	Dividend Junior	2023-07-07	Annually	17	0.39%
SMLT.NS	Dividend Knight	2023-08-09	Semi-Annually	3	0.64%
MIDHANI.NS	Dividend Junior	2023-09-22	Semi-Annually	7	1.04%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0671	1.500	8.66	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.0582	1.500	-0.464	-0.696	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	5.27	1.000	9.16	9.16	[3 - 30]
operatingCashFlowPerShareTTM	10.97	2.00	6.34	10.00	[0 - 30]
freeCashFlowPerShareTTM	10.97	2.00	4.51	9.03	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.469	1.000	5.52	5.52	[0.2 - 0.8]
operatingProfitMarginTTM	0.104	1.000	9.92	9.92	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.57

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	63.35	1.000	3.70	0	[1 - 100]
returnOnEquityTTM	0.0582	2.50	-0.298	-0.696	[0.1 - 1.5]
freeCashFlowPerShareTTM	10.97	2.00	6.34	9.03	[0 - 30]
dividendYielPercentageTTM	0.174	1.500	5.64	0	[0 - 0.4]
operatingCashFlowPerShareTTM	10.97	2.00	6.34	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.136	1.500	-4.24	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0814	1.000	-0.466	0	[0.1 - 0.5]
Total Score				2.46

Medicamen Biotech Limited

Medicamen Biotech Limited manufactures and sells pharmaceutical formulations in India. The company offers its products in various forms, including tablets, capsules, liquid and dry syrups, and ointments. It also provides oral rehydration solution, mouth wash, and dental care products. The company was incorporated in 1993 and is based in New Delhi, India.